Evelo Biosciences, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
8.00
|
|
Average Rating
|
4.17
|
|
# Strong Buys
|
3
|
|
# Buys
|
1
|
|
# Holds
|
2
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.33
|
-0.28
|
0.05
|
15.15%
|
|
2022-06-30
|
-0.43
|
-0.40
|
0.03
|
6.98%
|
|
2022-03-31
|
-0.58
|
-0.56
|
0.02
|
3.45%
|
|
2021-12-31
|
-0.61
|
-0.54
|
0.07
|
11.48%
|
|
2021-09-30
|
-0.54
|
-0.63
|
-0.09
|
-16.67%
|
|
2021-06-30
|
-0.54
|
-0.59
|
-0.05
|
-9.26%
|
|
2021-03-31
|
-0.51
|
-0.55
|
-0.04
|
-7.84%
|
|
2020-12-31
|
-0.53
|
-0.62
|
-0.09
|
-16.98%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-1.24
|
|
2021-12-31
|
-2.31
|
|
2020-12-31
|
-2.41
|
|
2019-12-31
|
-2.66
|
|
2018-12-31
|
-4.35
|
|
2017-12-31
|
-0.21
|